Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

4.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

91
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
91

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights from PSMAfore: impact on health-related quality of life.

Translational andrology and urology·2026
Same author

Assessing therapeutic response to Radium-223.

Seminars in nuclear medicine·2025
Same author

Quantitative SISCOM assessment for epileptogenic zone localization: insights from a multicenter study comparing two software platforms in temporal lobe epilepsy.

Frontiers in neurology·2025
Same author

Brazilian profile of Radium-223 in metastatic prostate cancer: a multicentric, retrospective study.

EJNMMI reports·2025
Same author

Theranostics Nuclear Medicine in Prostate Cancer.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

68 Ga-DOTATATE PET/CT Versus 18 F-FDG PET/CT in TENIS Syndrome: A Head-to-Head Comparison With Elevated and Suppressed TSH Levels in Papillary Thyroid Carcinoma-A Pilot Study.

Clinical nuclear medicine·2024

Related Experiment Video

Updated: Jun 10, 2025

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography
09:57

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography

Published on: January 11, 2020

7.4K

18F-Fluoride PET/CT-Updates.

Ellen Nogueira-Lima1, Thiago Alves1, Elba Etchebehere1

  • 1Division of Nuclear Medicine, University of Campinas (UNICAMP), Campinas, SP, Brazil.

Seminars in Nuclear Medicine
|October 11, 2024
PubMed
Summary

Sodium Fluoride-18 PET/CT offers improved accuracy for detecting bone lesions in cancer and benign conditions. This advanced imaging technique provides molecular-level insights into bone metabolism, enhancing diagnostic capabilities.

More Related Videos

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT
10:02

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT

Published on: May 2, 2012

18.3K
Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
06:31

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain

Published on: August 8, 2019

7.3K

Related Experiment Videos

Last Updated: Jun 10, 2025

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography
09:57

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography

Published on: January 11, 2020

7.4K
Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT
10:02

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT

Published on: May 2, 2012

18.3K
Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
06:31

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain

Published on: August 8, 2019

7.3K

Area of Science:

  • Nuclear Medicine
  • Radiochemistry
  • Oncology
  • Orthopedics

Background:

  • Sodium Fluoride-18 (F-18) was an early bone-imaging agent, but its use declined with conventional scintigraphy.
  • Conventional bone scintigraphy is sensitive but lacks specificity for detecting bone metastases and benign bone disease.
  • The development of 3D Whole-Body Positron Emission Tomography combined with computed tomography (PET/CT) has led to the resurgence of F-18 imaging.

Purpose of the Study:

  • To review the updated clinical applications of Fluoride PET/CT.
  • To highlight its advantages in detecting bone lesions in oncological and benign conditions.
  • To explore its utility in assessing treatment response.

Main Methods:

  • Review of clinical literature on Sodium Fluoride-18 PET/CT (Fluoride PET/CT).
  • Comparison of Fluoride PET/CT with conventional bone scintigraphy.
  • Focus on diagnostic accuracy, sensitivity, and specificity in various bone disorders.

Main Results:

  • Fluoride PET/CT demonstrates higher sensitivity and specificity than conventional bone scintigraphy for detecting bone lesions.
  • It provides detailed molecular-level information on bone metabolism and remodeling.
  • The technique enhances diagnostic accuracy by combining anatomical and metabolic data.

Conclusions:

  • Fluoride PET/CT is a valuable tool for diagnosing bone metastases and benign bone and joint disorders.
  • It offers superior diagnostic performance compared to traditional methods.
  • The review covers applications in oncology, orthopedics, inflammatory, and cardiovascular conditions, plus treatment response assessment.